Novel Benzoxazine-Based Aglycones Block Glucose Uptake In Vivo by Inhibiting Glycosidases
Figure 3
In vivo effect of compound 7 {4-(7-chloro-2,4-dihydro-1H-benzo[d][1,3]oxazin-2-yl)phenol} and acarbose on plasma glucose concentration by oral (A) maltose and (B) sucrose tolerance test.
Values are presented as mean ± SEM (n = 5). *p<0.05, **p<0.01, ***p<0.001 significant compared to respective maltose/sucrose alone treated groups.